A Study of the Safety and Tolerability of the Addition of CHR-2797 to Paclitaxel in Patients With Advanced or Refractory Tumours
Clinical trial NCT00737555 · COMPLETED
Trial details
- NCT number
- NCT00737555
- Sponsor
- Chroma Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2008-03-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.